Metraipolis › archive › dc_005478d7fc80

Buspirone attenuates cyclophosphamide-induced renal dysfunction in association with alterations in miR-205/EGLN2, Nrf2, and PERK/ATF4/CHOP signaling — Europe PMC PMID:42694385

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42694385
DOI: 10.3389/fphar.2026.1871321
License (as archived): solo-consultazione
Archived: 2026-10-08T02:34:06.081Z
SHA-256 of the archived text: 6b1ea0c6e4152fa1bc51e616ff8a6f0bde267c49dc723eba6be9e4f5424a8858
Stable URL of this page: https://metraipolis.com/documento/dc_005478d7fc80

How to cite

Buspirone attenuates cyclophosphamide-induced renal dysfunction in association with alterations in miR-205/EGLN2, Nrf2, and PERK/ATF4/CHOP signaling — Europe PMC PMID:42694385 — Europe PMC (en), https://europepmc.org/article/MED/42694385 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_005478d7fc80 (Metraipolis archive dc_005478d7fc80, sha256 6b1ea0c6e4152fa1bc51e616ff8a6f0bde267c49dc723eba6be9e4f5424a8858)

BibTeX

@misc{dc005478d7fc80,
  title = {Buspirone attenuates cyclophosphamide-induced renal dysfunction in association with alterations in miR-205/EGLN2, Nrf2, and PERK/ATF4/CHOP signaling — Europe PMC PMID:42694385},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42694385},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_005478d7fc80; sha256 6b1ea0c6e4152fa1bc51e616ff8a6f0bde267c49dc723eba6be9e4f5424a8858},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42694385. Agents can read the archived copy with the MCP tool read_document.